SEROQUEL

NDC 61269-270 · H2-Pharma, LLC

Generic namequetiapine

Dosage formTABLET, EXTENDED RELEASE

RouteORAL

Active ingredient(s)QUETIAPINE FUMARATE

Strength50 mg/1

Pharmacologic classAtypical Antipsychotic [EPC]

Marketing categoryNDA

Packages

61269-270-60 — 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-270-60)

FDA lists these products with the same active ingredient.

60760-762 — quetiapine fumarate, 60760-763 — quetiapine fumarate, 60760-764 — Quetiapine Fumarate, 60760-866 — Quetiapine, 61269-250 — quetiapine, 61269-251 — quetiapine, 61269-252 — quetiapine, 61269-253 — quetiapine, 61269-254 — quetiapine, 61269-255 — quetiapine, 61269-271 — quetiapine, 61269-272 — quetiapine, 61269-273 — quetiapine, 61269-274 — quetiapine, 63187-219 — Quetiapine fumarate, 63187-269 — Quetiapine fumarate, 63187-452 — Quetiapine fumarate, 63629-4776 — QUETIAPINE FUMARATE, 63629-4841 — QUETIAPINE FUMARATE, 63629-4964 — QUETIAPINE FUMARATE, +323 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.